What is watchful waiting and is it appropriate for my Melanoma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Watchful Waiting and Melanoma: What You Need to Know
What is Watchful Waiting?
Watchful waiting (also called observation) is a monitoring approach where your healthcare team regularly examines you for signs of cancer recurrence or new melanomas, rather than immediately starting treatment. During this time, you receive:
- Regular skin exams by your dermatologist (skin specialist)
- Physical exams to check lymph nodes
- Imaging tests when appropriate based on your stage
- Self-examinations at home using the ABCDE rule
Think of it as active surveillance—you're not doing nothing, but rather carefully watching for any changes that would trigger treatment.
When Watchful Waiting May Be Appropriate for Melanoma
According to the NCCN Guidelines for Patients: Melanoma (2025), observation is considered in specific situations:
✅ Situations Where Observation May Be Recommended:
After successful treatment with no evidence of disease:
- If you've had surgery to remove your melanoma and there's no cancer remaining
- If you've received systemic therapy (immunotherapy or targeted therapy) and imaging shows complete response (no cancer visible)
- If you've had T-VEC (intralesional therapy) injections with no remaining cancer
For early-stage melanoma:
- Stage 0-2 melanomas (localized to the skin) may be managed with surgery alone, followed by observation
For stage 3 regional disease: According to NCCN Guidelines, after certain treatments like T-VEC or systemic therapy with no evidence of disease remaining, observation is listed as one of the adjuvant (follow-up) therapy options.
What Watchful Waiting Does NOT Mean
❌ Watchful waiting is NOT appropriate if:
- You have active, visible cancer that hasn't been treated
- You have unresectable disease (cancer that can't be surgically removed)
- You have metastatic melanoma (stage 4, spread to distant organs)
- Your cancer is progressing despite treatment
In these situations, active treatment with systemic therapy, surgery, radiation, or other approaches would be recommended.
Your Follow-Up Schedule During Observation
According to the NCCN Guidelines, your care team will typically:
- Examine your skin and lymph nodes at least once per year
- Adjust frequency based on your stage and risk of recurrence (higher-risk patients may need more frequent visits)
- Teach you self-examination techniques so you can monitor between appointments
- Use specialized devices to help detect new melanomas early
Important Questions to Ask Your Oncologist
Since watchful waiting is highly individualized based on YOUR specific situation, ask your care team:
-
"Based on my stage and treatment response, is observation appropriate for me right now?"
-
"How often should I have follow-up exams, and what will those include?"
-
"What specific signs or symptoms should prompt me to contact you immediately?"
-
"Are there any imaging tests (CT scans, PET scans) I should have during observation?"
-
"If new melanoma or recurrence is detected, what treatment options would we discuss?"
The Bottom Line
Watchful waiting can be an appropriate and effective approach for melanoma patients after successful treatment with no evidence of disease remaining. However, it's only suitable in specific clinical situations. The NCCN Guidelines emphasize that observation decisions must be individualized based on your:
- Cancer stage
- Treatment response
- Risk factors for recurrence
- Overall health
Your oncologist will determine whether observation is the right approach for YOUR specific case based on your complete clinical picture.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Melanoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Melanoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: